cordycepin has been researched along with Cirrhosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, BL; Li, JR; Peng, B; Si, N; Sun, W; Wang, HJ; Yang, J; Zhao, HY | 1 |
Duan, MX; Huang, R; Huang, SH; Liu, LB; Ma, ZG; Tang, QZ; Wan, CX; Wang, HB; Wu, QQ; Xu, M; Yang, J | 1 |
Bian, RW; Gu, LB; Hu, H; Sun, W; Tu, Y; Wan, YG | 1 |
3 other study(ies) available for cordycepin and Cirrhosis
Article | Year |
---|---|
[Study on characteristic spectrum of ingredients from different species Cordyceps and its anti-fibrotic activity on human embryonic fibroblasts].
Topics: Adenosine; Cells, Cultured; Cordyceps; Deoxyadenosines; Fibroblasts; Fibrosis; Humans; Transforming Growth Factor beta1; Uridine | 2016 |
Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Deoxyadenosines; Fibrosis; Hemodynamics; Male; Mice, Inbred C57BL; Models, Biological; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Pressure; Signal Transduction | 2019 |
[Mechanisms of cordycepin on improving renal interstitial fibrosis via regulating eIF2α/TGF-β/Smad signaling pathway].
Topics: Actins; Animals; Deoxyadenosines; Fibrosis; Kidney; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2014 |